{"disease":{"id":"solar-urticaria","name":"solar urticaria"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02262130","title":"Omalizumab in Severe and Refractory Solar Urticaria","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Centre Hospitalier Universitaire de Besancon","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}